 CHESTER, N.Y.--BUSINESS WIRE--First paragraph, first sentence of release dated February 16, 2022, should read: Repro Med Systems, Inc. dba KORU Medical Systems NASDAQ: KRMD KORU Medical or the Company, a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report fourth quarter and full year 2021 financial results on Wednesday, March 2, 2022. instead of Repro Med Systems, Inc. dba KO 